2018 American Transplant Congress Archives

Ideal Body Weight versus Actual Body Weight for Rabbit Antithymocyte Globulin Induction in Pancreas Transplantation

E. Martinez,¹ D. Felix,² J. Wiegel,² T. Al-Qaoud,¹ G. Leverson,¹ A. Condon,² R. Redfield,¹ J. Odorico.¹
Identification of Anti-Inflammatory and Pro-Inflammatory Gut Microbiota That Determine Graft Survival

Y. Xiong, C. Brinkman, L. Hittle, W. Fricke, E. Mongodin, J. Bromberg.
Identification of Exosomal Isletokines Released by Pancreatic Islets in Response to Inflammatory Stress

P. Saravanan,¹ G. Yoshimatsu,¹ R. Bhattacharjee,¹ C. Chang,¹ C. Darden,¹ B. Naziruddin,² M. Lawrence.¹
Identification of Exosomal Proteins from Human Lung Transplant Recipients

S. Bansal,¹ P. Pirrotte,² M. Saltzman,² K. Garcia,² M. Sharma,¹ M. Gunasekaran,¹ M. Smith,¹ R. Bremner,¹ T. Mohanakumar.¹
Identification of Human SIRPa Diversity That Could Regulate Innate Allorecognition

A. Friday,¹ H. Dai,¹ A. Williams,¹ M. Oberbarnscheidt,¹ J. Danska,² F. Lakkis.¹
Identification of Macrophage Innate Receptors in Recognition and Rejection of Allogeneic Non-Self in Transplantation

P. Lan,¹ H. Dai,² W. Liu,¹ S. Chen,¹ L. Minze,¹ Y. Dou,¹ Y. Zhao,¹ W. Chen,¹ X. Xiao,¹ P. Pan,¹ H-.H. Chen,¹ F. Lakkis,² X. Li.¹
Identification of Noninvasive and Mechanistically-Informative Biomarkers Predictive of Reversal of Acute Cellular Rejection (ACR) in Kidney Allografts

D. Luan,¹ J. Schwartz,² R. Ding,² T. Muthukumar,² D. Dadhania,² M. Suthanthiran.²
Identification of Novel Genetic Variants Associated with Tacrolimus Metabolism in Kidney Transplant Recipients Using Next Generation Sequencing

C. Dorr,^1,2,3 B. Wu,² R. Remmel,² A. Muthusamy,¹ D. Schladt,¹ J. Abrahante,² W. Guan,² R. Mannon,⁴ A. Matas,² W. Oetting,² P. Jacobson,² A. Israni.^1,2,3
Identification of T Cells as Target of Intervention to Decrease Anti-LG3 Autoantibody Levels Prior to Transplantation

M. Dieudé, L. Padet, A. Karakeussian-Rimbaud, B. Yang, J. Turgeon, H. Cardinal, M-.J. Hébert.
Identifying Differences in Antimicrobial Resistance with a Liver Transplant Antibiogram

J. Rago, M. Crotty, E. Milas, E. Dominguez.
Identifying Patients at Risk of Mortality and Major Adverse Cardiovascular Events Following Simultaneous Pancreas and Kidney Transplantation Using the Pre-Transplant QRISK2 Score

P. Yiannoullou,^1,2 S. Goh,² H. Khambalia,^1,2 Z. Moinuddin,^1,2 A. Summers,^1,2 I. Shapey,^1,2 C. Fullwood,² T. Augustine,^1,2 M. Rutter,^1,2 D. van Dellen.^1,2
Identifying Patients with CPRA>99.95% Likely to Be Offered Deceased Donor Kidneys

R. Parsons, S. Bumb, H. Decker, R. Bray, H. Gebel.
Identifying Specificity Groups in the CMV IE-1 T Cell Receptor Repertoire

M. Lucia,¹ F. Rubelt,² S. Luque,³ S. Krams,¹ C. Esquivel,¹ O. Bestard,³ O. Martinez.¹
Identifying the Specific Causes of Kidney Allograft Loss: A Population Based Study

C. Loheac, O. Aubert, D. VIglietti, N. Kamar, M. Delahousse, C. Lefaucheur, A. Loupy.
IgA Recurrence in a Single Center with a Protocol Biopsy Program

M. Merzkani, N. Lepori, M. El Ters, F. Cosio, H. Amer.
IgG De Novo HLA Antibody Subclass Analysis in Patients Undergoing Allograft Nephrectomy after Transplant Failure

G. Lucisano,¹ A. Gueret-Wardle,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² N. Gunby,² S. Hassan,¹ M. Willicombe,¹ D. Taube.¹
IgM HLA DSAs Do Not Alter the Outcomes of Renal Allograft Rejection

A. Gueret-Wardle,¹ P. Dodd,¹ G. Lucisano,¹ S. Hassan,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² D. Goodall,¹ C. Roufosse,¹ M. Willicombe,¹ D. Taube.¹
IL-10 Requirement in In Vitro Expanded Breg-Mediated Allograft Tolerance is Tissue Specific

C. Dai, K. Lee, L. Kojima, K. Deng, S. Kimura, C. Rickert, H. Yeh, J. Markmann.
IL-17 is Critical for Airway Epithelial Injury after Transplantation

R. Zhang,¹ H. Fang,¹ Q. Chen,² J. Ochando,³ Y. Ding,¹ J. Xu.¹
IL-21 Regulates Creation of Tertiary Lymphoid Organs in Chronic Allograft Rejection

J. Breidenbach, C. Baum, P. Schroder, S. Stepkowski.
IL-6 Inhibition with Tocilizumab to Promote Tregs and Control Renal Graft Inflammation: A Prospective Randomized Controlled Trial

S. Chandran, J. Leung, Z. Laszik, Q. Tang, C. Hu, M. Sarwal, F. Vincenti.
IL23R is a Pathogenic Gene in Type 1 Regulatory T Cells during Mouse Cardiac Transplantation Models

G. Gu, T. Lu, N. Xu, Q. Xia.
Immune Modulatory Effect of Thalidomide and Dexamethasone Co-Treatment on Murine Splenocytes

E. Kim,^1,2 J. Kim,¹ K. Huh,^1,3 Y. Cho,¹ M. Kim,^1,3 Y. Kim,^1,3 B. Kim.^1,4
Immune Phenotyping in a Pediatric Multicenter Transplant Study: Suitability of a Pre-Formulated Dry Antibody Panel System

S. Urschel,¹ L. Ionescu,¹ T. Blydt-Hansen,³ B. Foster,⁵ S. Mital,² U. Allan,² S. Iveson,³ L. Hamiwka,⁴ J. Yap,¹ V. Phan,⁵ P. Birk,⁶ L. West,¹ M. Levings.³
Immune Profiling in Highly Sensitized Kidney Transplant Recipients

S. Negi, A. Rutman, S. Paraskevas, J. Tchervenkov.
Immunity and Tolerance after Bilateral Orthotopic Lung Transplant (BOLT) in Tandem with a CD3+/CD19+ Depleted Vertebral Bone Marrow Transplant (BOLT+BMT) from 1 of 8 HLA-Matched Cadaveric Donors

P. Szabolcs,¹ X. Chen,¹ A. Donnenberg,² M. Hill,¹ J. Rowan,¹ S. Mcintyre,¹ G. Kurland,¹ J. Barnum,¹ J. McDyer.¹
Immunogenic HLA Mismatches and Evidence That Belatacept May Be the First Therapy Able to Prevent DQ De Novo DSA: An Analysis of the BENEFIT and BENEFIT-EXT Trial Cohorts

M. Everly,¹ V. Jucaud,¹ M. Roberts,² H. Gebel,³ R. Bray.³
Immunoglobulin Replacement Therapy in Pediatric Renal Transplant Patients

A. Lewis, M. Fasano, D. Zepeda-Orozco.
Immunologic Impact of Tocilizumab Treatment in Kidney Transplant Recipients with Allograft Inflammation

J. Leung, S. Chandran, F. Vincenti, Q. Tang.
Immunomodulation of Alloantibody Responses

C. Schuetz, M. Climov, A. Paril, Z. Wang, A. Andrews Roy, N. Navarro Alvarez, A. Matar, D. Sachs, R. Duran-Struuck, C. Huang.
Immunomonitoring of Operational Tolerance in Intestinal Transplantation

O. Aguirre, B. Houlihan, T. Fishbein, A. Kroemer.
Immunophenotype of Cells Infiltrating the Graft Explains the Benefits of Belatacept

J. Furuzawa-Carballeda,¹ N. Uribe-Uribe,² G. Mondragon-Ramirez,⁴ J. Arreola-Guerra,⁵ R. Reyes-Acevedo,⁵ M. Vilatoba,³ R. Chavez-Fernandez,¹ F. Lopez-Verdugo,¹ A. Lopez-Toledo,⁴ G. Mondragon-Salgado,⁴ J. Alberu.³
Immunosuppression and the Risk of Dementia among Older Kidney Transplant Recipients

M. McAdams DeMarco,¹ C. Haugen,¹ S. Bae,¹ K. Lentine,² D. Segev.¹
Immunosuppression Does Not Affect Adverse Pathological Outcomes in Men Who Underwent Radical Prostatectomy

M. Eltemamy, A. Elshafei, Y. Nyame, A. Crane, A. Wee, V. Krishnamurthi, E. Klein, S. Jones.
Immuoadsorption-Based Desensitization in Highly Sensitized Patients Awaiting Deceased Donor Kidney Transplantation.

C. Bureau, P. Galichon, Y. Luque, N. Ouali, E. Rondeau, C. Rafat.
Impact of a Steroid Free Immunosuppressive Regimen on Patient and Graft Outcomes in Pancreas Transplant Recipients

M. Cote,¹ C. Rogers,¹ K. Khwaja,² A. Evenson,² M. Pavlakis,² K. Richards.¹
Impact of AB0-Incompatible Kidney Transplantation on Lymphocele Formation

C. Salabe,¹ S. Zschiedrich,² P. Pisarski,¹ B. Jänigen.¹
Impact of Aberrant Post-Transplant Laboratory and Blood Pressure Values on Graft Survival and Racial Disparities in Kidney Transplant

D. Taber, Z. Su, J. Fleming, N. Pilch, A. Posadas, V. Rao, P. Mauldin, D. Dubay.
Impact of Age and Race on BK Viremia among Kidney Transplant Recipients

S. Mehta,^1,3 N. Ali,^1,3 B. Lonze,^2,3 A. Stachel.³
Impact of Ambulatory Transplant Pharmacy Services on Outcomes and Readmissions in Adult Abdominal Transplant Recipients

K. Joyal,¹ C. Rogers,² M. Cote,² M. Pavlakis,² A. Evenson,² V. Patwardhan,² K. Richards.²
Impact of an Anastomosis Time on Transplant Outcomes in Deceased Donor Kidney Transplantation

K. Jeong, H. Jung, J. Choi, J-.H. Lim, J. Choi, J-.H. Cho, S-.H. Park, Y-.L. Kim, C-.D. Kim.
Impact of Antecedent Malignancy on Kidney Transplant Outcomes: Patient, Graft, and Cancer-Free Survival

O. Serrano,¹ S. Mongin,² D. Berglund,¹ D. Vock,³ S. Chinnakotla,¹ T. Dunn,¹ E. Finger,¹ R. Kandaswamy,¹ T. Pruett,¹ A. Matas.¹
Impact of Aortic Abdominal Calcification among Living Donor Liver Transplant Recipients; a Retrospective Study

Y. Imaoka, M. Ohira, S. Simizu, H. Tahara, K. Ide, Y. Tanaka, H. Ohdan.
Impact of Balanced Solutions on Acid Base Disorders during and after Kidney Transplantation

N. Maillard,² H. Chraka,¹ G. Claisse,² E. Alamartine,² S. Molliex,¹ C. Mariat.²
Impact of Bw4 and Bw6 Epitope Mismatch on Clinical Outcomes after Renal Transplantation

C. Liu,¹ D. Brennan,² K. Lentine,³ R. Delos Santos,¹ J. Li,¹ A. Malone,¹ T. Alhamad.¹
Impact of Center Volume on Kidney Transplant Outcomes in Contemporary U.S. Transplant Practice

T. Alhamad,¹ F. Abbas,¹ D. Brennan,² A. Malone,¹ J. Wellen,¹ R. Delos Santos,¹ A. Khan,¹ J. Li,¹ R. Rattanavich,¹ K. Lentine.³
Impact of Changes to the LAS Calculation

R. Lehman,¹ R. Carrico,¹ K. Uccellini,¹ K. Chan,² T. Whelan.³
Impact of Cigarette Smoking on Living Kidney Donor

Y. Yoon,¹ H. Lee,² J. Na,³ K. Huh,⁴ M. Kim,⁴ S. Kim,⁴ Y. Kim,⁴ W. Han.³
Impact of De Novo DSA (DnDSA) on Outcomes in HLA-Sensitized (HS) Patients Transplanted after IVIG + Rituximab Desensitization (DES)

A. Vo,¹ O. Aubert,² H. Edmund,¹ A. Peng,¹ R. Najjar,¹ S. Supreet,¹ J. Choi,¹ K. Lim,¹ S. Jordan.¹
Impact of De Novo DSA Development and Management on Kidney Transplant Outcomes

M. Cote,¹ M. Pavlakis,² F. Cardarelli,² J. Pena,³ A. Dinh,³ K. Richards,¹ K. Joyal,¹ C. Rogers.¹
Impact of Direct Acting Antiviral Agents (DAAs) for Hepatitis C Virus (HCV)-Induced Liver Diseases on Registration and Outcome on Waiting List (WL) for Liver Transplant (LT)

C. Antoine,¹ C. Jasseron,¹ F. Conti,² S. Dharancy,³ C. Duvoux,⁴ A. Coilly.⁵
Impact of Direct Acting Antivirals of Hepatitis C Virus Therapy on Tacrolimus Dosing Post-Liver Transplant

A. Bixby, L. Fitzgerald, R. Leek, J. Mellinger, S. Tischer.
Impact of Direct Antiviral Therapy for Hepatitis C on Acute Rejection and DSA Formation in Kidney Transplant Recipients

Z. Zaky, S. Armanyous, L. Herlitz, E. Poggio, J. Augustine.
Impact of Donation after Cardiac Death Allografts on Outcome Following Liver Transplantation for Fulminant Hepatic Failure: An Analysis of the UNOS Database

S. Kumar,¹ S. Lin,² J. Schold.²
Impact of Donor Age on Outcomes after Living Donor Liver Transplantation

K. Hayashi,¹ K. Gotoh,¹ H. Eguchi,¹ Y. Iwagami,¹ D. Yamada,¹ T. Asaoka,¹ T. Noda,¹ K. Kawamoto,¹ S. Kobayashi,¹ K. Umeshita,² Y. Doki,¹ M. Mori.¹
Impact of Donor Hepatectomy Time during Organ Procurement in Donation after Circulatory Death Liver Transplantation; The United Kingdom Experience

S. Farid, A. Magdy, D. Vijayanand, V. Upasani, S. Willis, A. Barlow, H. Ernest, A. Niaz.
Impact of Early Corticosteroid Treatment in Patients with Indeterminate Acute Severe Hepatitis

E. Mohr,¹ R. Sucher,² T. Müller,³ T. Kaiser,⁴ T. Berg.¹
Impact of ELAD C3A Cell Conditioned Medium Enhanced Perfusate Fluid on Functional Recovery of Extended Criteria Donor Livers during Normothermic Machine Perfusion

S. Afford,² L. Wallace,² R. Laing,² Y. Botteon,² D. He,³ S. Soundararajan,⁴ D. Mirza,¹ R. Ashley,³ J. Brotherton,³ H. Mergental,¹ D. Reich.⁴
Impact of Elderly Donor Obesity on Long-Term Outcomes in Renal Transplant Recipients

M. Yamada,¹ R. Jandarov,² T. Kaur,¹ S. Shah.¹
Impact of Elevated PSA, and Prostate Cancer in ESRD on Time to Transplant, and Survival

N. Sarabu,¹ N. Schiltz,² D. Hricik.¹
Impact of Fluconazole Prophylaxis on Fungal Infections in Liver Transplant Recipients

K. Roach,¹ S. Todd,² M. Lyon,² R. Subramanian.²
Impact of Glomerular Filtration Rate Normalization to Body Surface Area on Donor Selection and Outcome in over 4000 Living Kidney Donors

S. Riad,¹ D. Keys,¹ D. Vock,¹ S. Jackson,¹ D. Berglund,¹ V. Vakil,¹ A. Matas,¹ H. Ibrahim.³
Impact of High Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant Recipients

J. Fose, M. Jorgenson, M. Siodlak, G. Leverson, J. Smith, R. Redfield.
Impact of Immediate Graft Function in Kidney Transplant Outcomes

C. Arias-Cabrales, M-.J. Pérez-Sáez, D. Redondo-Pachón, M. Crespo, M. Mir, J. Pascual.
Impact of Immunogenicity on Kidney Allograft Survival in Patients Treated with Induction Therapy

D. Bekbolsynov, B. Mierzejewska, M. Rees, J. Ortiz, O. Ekwenna, S. Stepkowski.
Impact of Infections on Patients with Left Ventricle Assist Devices(LVAD): Allo-Sensitization and Heart Transplantation

C. Buto-Colletti, P. Kimball, K. Shah, M. Quader.
Impact of Influenza Vaccine Implementation by Transplant Pharmacy in Solid Organ Transplant Recipients

S. Gattis,¹ I. Yildirim,^1,2 S. Serluco,¹ C. McCracken,² R. Liverman.¹
Impact of KDPI and CPRA on Outcomes in Kidney Transplant Recipients

S. Sethi, R. Najjar, A. Peng, A. Vo, S. Jordan, E. Huang.
Impact of Local Liver Supply on Liver Offer Acceptance

M. Bowring,¹ S. Zhou,¹ A. Massie,¹ S. Gentry,^1,2 D. Segev.¹
Impact of Lymphoceles after Kidney Transplantation on Long-Term Outcomes

L. Lehner, A. Hohberger, F. Halleck, E. Schrezenmeier, D. Khadzhynov, K. Budde, O. Staeck.
Impact of Mammalian Target of Rapamycin Inhibitors on Hepatocellular Carcinoma Recurrence after Liver Transplant

N. Hendon,¹ D. Salerno,¹ C. Sammons,¹ K. Halazun.²
Impact of New Pancreas Transplant Allocation Policy on Pancreas Transplant Volume and Outcomes: A Single Center Study

N. Singh, A. Pulisetty, D. Aultman, R. McMillan, G. Zibari, H. Shokouh-Amiri.
Impact of On-Site Overestimation of Macrosteatosis on Donor Liver Biopsy

M. Wright, J. Seal, L. De Gregorio, H. Bohorquez, D. Bruce, E. Bugeaud, I. Carmody, A. Mathur, D. Sonnier, G. Galliano, I. Oliva, L. Bratton, G. Loss.
Impact of Once-Daily Tacrolimus on Adherence in Stable Adolescent and Young Adult Renal Transplant Recipients

M. Moss,¹ J. Goebel,² M. Bock.²
Impact of Overseas Organ Transplantation on Outcome of Kidney Transplant Patients

M. Mammadli,¹ H. Ismayilov,¹ A. Asgarli,² F. Babayev,⁴ I. Hemidov,⁴ R. Shahbazov.³
Impact of Pneumocystis Prophylaxis on Incidence of Treated Urinary Tract Infections Following Kidney Transplantation

S. Sanchez, M. Brokhof, N. Kenyon, C. Varughese, N. Alvey.
Impact of Positive Donor Blood Cultures in Liver Transplant Recipients

D. Bley, D. Lo, G. Lyon III, R. Subramanian, S. Todd.
Impact of Postoperative Serum Chloride Changes on Graft Function and Acute Rejection in Recipients of Living Kidney Transplants

V. Vakil, D. Keys, M. Junghare, S. Jackson, D. Berglund, A. Matas, S. Riad.
Impact of Pre-Transplant Dialysis on ESRD-Free and Patient Survival in Heart Transplant Alone and in Simultaneous Heart/Kidney Transplant Recipients: UNOS Data Analysis

S. Akkina, A. Desai, J. Yoo, S. Hou, R. Parasuraman.
Impact of Pre-Transplant Non-Dialysis Renal Dysfunction in Heart Transplant Recipients on Post-Transplant ESRD: A UNOS Database Analysis

S. Akkina, A. Desai, J. Yoo, S. Hou, R. Parasuraman.
Impact of Preserved Collateral Veins on Small-for-Size Grafts in Living Donor Liver Transplantation

B-.G. Na, E. Lee, S. Kim, S. Park.
Impact of Pretransplant Donor-Specific Antibodies on Kidney Allograft Recipients with Negative Flow Cytometry Crossmatches

H. Kwon, Y. Kim, J. Choi, S. Shin, J. Jung, M. Cho, J. Kim, D. Han.
Impact of Providing Care Locally Compared to at a Transplant Center for Pre-And Posttransplant Liver Patients

R. Shahbazov,¹ K. Knapp,² S. Tsutsui,² A. Nickkholgh,¹ P. Northup,³ J. Oberholzer,¹ D. Maluf,¹ M. Shiffman,⁴ S. Pelletier.¹
Impact of Psychosocial Variables on Renal Allograft Rejection Risk: A Multivariate Analysis

D. Chernobylsky, K. Carsky, C. McDermott, P. Ferrin, R. Fernandez, I. Gaines, M. Killackey, R. Zhang, A. Paramesh, J. Buell.
Impact of Pulsatile Perfusion Machine on Postoperative Outcomes in Standard Criteria Donor Kidney Transplants

S. Costa,^1,2 T. Sandes-Freitas,^1,2 P. Fernandes,² R. Esmeraldo.¹
Impact of Rapid Discontinuation of Prednisone on Kidney Transplant Outcomes in At-Risk Subpopulations: An OPTN/SRTR Analysis

D. Vock,¹ A. Matas.²
Impact of Renal Parenchymal Calcifications in a Cohort of Renal Transplanted Patients and Their Correlations with Long Term Graft Outcome

C. Alfieri,¹ G. Moroni,¹ D. Cresseri,¹ A. Regalia,¹ F. Zanoni,¹ V. Binda,¹ M. Gandolfo,¹ M. Campise,¹ M. Meneghini,¹ M. Ikehata,¹ P. Messa.^1,2
Impact of Sever Hypoxemia after Liver Tansplantation in Hepatopulmonary Syndrome

M. Pitchaimuthu, M. Fujiki, K. Sasaki, K. Hashimoto, B. Eghtesad, C. Miller, C. Quintini.
Impact of Single Nucleotide Polymorphisms on P450 Oxidoreductase and Peroxisome Proliferator-Activated Receptor alpha on Tacrolimus Pharmacokinetics in Renal Transplant Recipients

Z. Wang, Z. Han, J. Tao, H. Chen, S. Li, R. Tan, M. Gu.
Impact of Sleep Apnea Syndrome on Late Graft Dysfunction

A. Afzal,¹ K. Tecson,² A. Jamil,³ A. Wazir,¹ J. Felius,³ H. Qin,³ P. Garcha,¹ S. Carey,¹ S. Hall.¹
Impact of Steroid Maintenance on the Outcomes of HLA-DR Mismatch Kidney Transplantation

B. Chopra, K. Sureshkumar.
Impact of the Differences between Body Mass Index of Recipient and Donor in a Population of Robotic Kidney Transplant

K. Tulla,¹ I. Tzvetanov,¹ C. Di Bella,¹ F. Gheza,¹ M. Spaggiari,¹ J. Oberholzer,² E. Benedetti.¹
Impact of the Kidney Allocation System on Young Pediatric Recipients

W. Parker,¹ L. Ross,¹ J. Thistlethwaite,¹ A. Gallo.²
Impact of the New KAS on Transplant Rates in Highly-HLA Sensitized (HS) Patients after Desenstization (DES): 3yrs Post Implementation

A. Vo, E. Huang, N. Ammerman, S. Williamson, C. Myers, A. Peng, R. Najjar, S. Sethi, K. Lim, S. Jordan.
Impact of the New Kidney Allocation System A2/A2B –> B Policy on Access to Transplantation among Minority Candidates

M. Mustian,¹ P. Martins,² P. MacLennan,¹ J. Ortiz,² J. Caicedo,² S. Gray,^1,2 B. Kelly,² C. Esquivel,² ASTS Diversity Affairs Commmittee,² J. Locke.^1,2
Impact of Total Graft Steatotic Mass in Liver Transplant Outcomes

L. De Gregorio,¹ E. Bugeaud,¹ G. Galliano,² H. Bohorquez,¹ D. Bruce,¹ I. Carmody,¹ A. Cohen,¹ J. Seal,¹ D. Sonnier,¹ A. Mathur,¹ G. Loss.¹
Impact of Vitamin D Status on Immune-Mediated Graft Function Following Kidney Transplantation

C. Pham,¹ B. Pierce,¹ S. Bapat,² S. Kuten,¹ L. Moore,³ A. Gaber.³
Impacts of HBsAg Seropositive Status on Patient and Graft Survival after Kidney Transplantation in the Era of New Antiviral Therapy: A Meta-Analysis

N. Leeaphorn,¹ C. Thongprayoon,² K. Sharma,² A. Sakhuja,³ W. Cheungpasitporn.⁴
Implementation of Intensive Standardized Follow-Up in Kidney Transplant Recipients

A. Crane, M. Eltemamy, T. Coy, P. Babbar, A. Sun, D. Jacobsen, M. Ponziano, E. Poggio, A. Wee, R. Fatica, V. Krishnamurthi.
Implementation of the Lung Allocation Score is Associated with Decreased Mortality in Combined Liver-Lung Allograft Recipients

K. Freischlag,¹ P. Shroder,² B. Ezekian,² M. Mulvihill,² S. Knechtle.²
Implementing Mobile Health Technology for Living Kidney Donor Follow-Up: Transplant Provider Perspectives

A. Eno,¹ J. Ruck,¹ S. Rasmussen,¹ D. Segev,^1,2 M. Henderson.¹
Improved Cardiac Risk Stratification Method in Kidney Transplant Candidates.

L. Punnoose, N. Fonseka, M. Lashner, G. Mythili, S. Rao.
Improved Long-Term Outcomes of Pancreas Transplantation: Analysis of Allograft Half-Lives and Predictive Demographic Factors

A. Adamusiak, R. Kandaswamy, T. Dunn, S. Riad, E. Finger.
Improved Mouse Renal Transplantation Model Mimicking Clinical Antibody Mediated Rejection

D. Zhao,¹ T. Liao,¹ S. Li,¹ J. Zhou,² F. Han,¹ Y. Dong,³ Q. Sun.¹
Improved OPO Performance Drives Broader Organ Sharing in the United States

R. Carrico, B. Shepard, D. Klassen.
Improved Renal Allograft Survival for Pre-Emptive Paediatric Renal Transplant Recipients in the United Kingdom

M. Marlais,¹ K. Martin,² S. Marks.¹
Improved Value with Individualized Antithymocyte Globulin Dosing Protocol in Renal Transplant

J. Dann, W. Ally, M. Bradley, J. Geyston, A. Agarwal.
Improvement in Intermediate Graft Survival among Deceased Donor Recipients in the Last Decade Due to Improvements in Outcomes of Higher KDPI Kidney Recipients

D. Keith.
Improvement of Metabolic Function after Intra-Portal Allogeneic Islet Transplantation by Induction Treatment of the Non-Hematopoetic Erytropoetin Analogue Cibinetide in a Mouse Model

M. Yao,¹ M. Watanabe,^1,2 S. Sun,¹ B. Ericzon,¹ T. Lundgren,¹ M. Kumagai-Braesch.¹
Improving and Delivering Medical Education about Organ Donation and Transplantation to Medical Students Could Play a Fundamental Role in Organ Donation Expansion: Its Time to Get the Basics Right.

A. Ghazanfar, E. Vyra.
Improving DCD Livers Graft Function Using CD47 Blockade in the Setting of Normothermic Liver Perfusion

S. Garcia-Aroz,¹ M. Xu,¹ X. Wang,¹ J. Hollingshead,¹ A. Khan,¹ B. Banan,¹ L. Kang,² Z. Zhang,¹ G. Upadhya,¹ Y. Lin,¹ P. Manning,³ W. Chapman.¹
Improving Organ Donation Rates through a Primary Care Physician Office-Based Intervention

R. Kashyap,¹ M. Dokus,¹ N. Ryan,³ A. James,³ R. Kochik,³ R. Hernandez,¹ J. Dolan,² P. Veazie,² M. Orloff,¹ S. McIntosh.²
Improving Participation in Non-A1/Non-A1B to B Deceased Donor Program Post Kidney Allocation System (KAS)- A Single Center Experience

H. Khamash, J. Adamski, R. Heilman, A. Mathur, A. Moss, A. Kumar, Q. Lu, K. Reddy.
Improving Prediction of Post-Transplant Death and Graft Loss with Expanded Clinical Data Collection

R. Sung,¹ J. Magee,¹ M. Schnitzler,² N. Dzebisashvili,³ K. Lentine,² L. Ly,¹ D. Axelrod.⁴
Improving Prognostication amongst Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: An International, 16-Center Study to Validate and Recalibrate HALTHCC

D. Firl,¹ K. Sasaki,¹ S. Kimura,² W. Dumronggittigule,³ A. Gorgen,⁴ J. Lerut,⁵ M. Rossi,⁶ U. Cillo,⁷ A. Viveiros,⁸ E. Tsochatzis,⁹ G. Otto,¹⁰ G. Ettorre,¹¹ G. Tisone,¹² M. Vivarelli,¹³ S. Agnes,¹⁴ J. Markmann,² T. Ikegami,¹⁵ T. Kaido,¹⁶ G. Sapisochin,⁴ V. Agopian,³ Q. Lai,^5,6 F. Aucejo.¹
Improving the Organ Donation Referral Process through Telemedicine

M. Groveman,¹ M. Perry,² I. Berman,² N. Benavides,¹ A. Friedman.¹
In Vitro α-Galactosylceramide Stimulation Expands CD4⁺CD25⁺Foxp3⁻ Regulatory T Cell Precursors in Murine Thymocytes

H. Katsumata,^1,2 M. Ikemiyagi,¹ T. Kanzawa,¹ H. Fukuda,¹ R. Ishii,¹ K. Saiga,^1,3 M. Okumi,¹ Y. Ishii,⁴ K. Tanabe.¹
In Vivo Allograft Exposure to Mitochondrial DAMPs Prior to Organ Procurement Increases Graft Rejection in Mice

L. Lin, J. Wang, L. Cendales, A. Kirk, T. Brennan.
In-Situ Tissue-Based Gene Expression Profiling is a Reliable Method to Detect Gene Transcripts in Human Kidney Transplant Biopsies

D. Dobi,¹ J. Henrik,² T. Sigdel,² A. Chen,¹ Z. Laszik.¹
In-Vivo Visualization of Regulatory B Cells Reveals Ag-Dependent T Cell Interactions That Suppress Subsequent T Cell:DC Interactions

K. Mohib, A. Cherukuri, Y. Zhou, R. David.
Incidence of Acute Cellular Rejection in Liver Transplant Patients Receiving Direct Acting Antivirals for Hepatitis C Treatment

D. Bley,¹ L. Sagardia,¹ R. Ford,² S. Todd.¹
Incidence of Atrial Arrhythmia after Lung Transplantation with a Universal Prophylaxis Strategy

M. Sullivan,¹ J. Lin,² R. Bag,² L. Potter.¹
Incidence of BK Viraemia and BK Virus Associated Nephropathy with Standard vs. Augmented Immunosuppression

R. Rathore, S. Anastassiadou, A. Kaur, J. Timms, N. Krishnan.
Incidence of Epstein Barr Virus (EBV) DNAemia in EBV-Seronegative Solid Organ Transplant (SOT) Recipients with EBV-Seropositive Donors

C. Burton,¹ C. Mabilangan,² J. Preiksaitis.²
Incidence of Pneumonitis in Heart Transplant Patients Started on a Proliferation Signal Inhibitor

R. Levine, J. Patel, M. Levine, M. Kittleson, E. Kransdorf, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Incidence of Rejection and Antibody Formation after Immunosuppression Reduction in Patients with Biopsy Proven Polyomavirus Nephropathy

M. Kleman, R. Detwiler, H. Singh, V. Nickeleit.
Incidence Trends among Deceased Liver Transplant Recipients in the United States, 2011-2016: A Propensity Score-Matched Study

R. Schilke, M. Safwan, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.
Incisional Hernia after Orthotropic Liver Transplantation: A Systematic Review and Meta-Analysis

J. Butler, D. O'Brien, J. Kays, C. Kubal, B. Ekser, J. Fridell, R. Mangus, J. Powelson.
Incisional Hernia Repair after Abdominal Solid Organ Transplant and Living Kidney Donation: A Single Institution Experience

C. Kensinger,¹ S. Phillips,² D. Hale,² D. Shaffer,² B. Poulose,² R. Baucom.³
Increase in Potentially Resistant Non-Aspergillus Molds Isolated in Lung Transplant Recipients after Voriconazole and Posaconazole Prophylaxis

M. Fung,¹ J. Greenland,^2,3 S. Hays,² J. Singer,² J. Golden,² P. Chin-Hong.¹
Increase on Regulatory Cells in Kidney Transplanted Patients Presenting Donor-Specific Antibodies

G. Maciel,¹ M. Fernandes,^1,2 E. Barbosa,² H. Rodrigues,¹ N. Panajotopolus,¹ F. Agena,² E. David-Neto,² V. Coelho,¹ M. Castro.²
Increased BMI is a Predictor of Early Post-Transplant Cardiac Events and Mortality

A. Mahgoub, S. Jackson, J. Lake, N. Lim.
Increased Expression of CEACAM1 is Cytoprotective during Ischemia-Reperfusion Injury in Human Orthotopic Liver Transplantation

R. Sosa,¹ J. Nevarez-Mejia,¹ M. Rossetti,¹ A. Zarrinpar,² F. Kaldas,² C. Lassman,¹ B. Naini,¹ N. Datta,² R. Busuttil,² D. Gjertson,¹ J. Kupiec-Weglinski,² E. Reed.¹
Increased Expression of HLA-DPB1 in Pre-Implantation Kidney Biopsies is Associated with Poor Late Graft Function

K. Mine,¹ T. Mourão,¹ C. Felipe,² G. Rampim,¹ J. Medina-Pestana,² H. Tedesco-Silva,² M. Gerbase-DeLima.¹
Increased Gene Expression of TGF-b in Renal Transplant Patients with Polyomavirus BK Viremia

W. Yin.
Increased Length of Stay of the Donor Decreases Heart Transplant Recipient Survival

H. Copeland,¹ R. Talluri,² A. Panos,¹ R. Cochran,¹ L. Creswell,¹ D. Baran.³
Increased Pre-Transplant Rejection-Risk Measured with Allospecific T-Cells Predicts Delayed Immunosuppression Minimization in Children with Intestine Transplantation.

K. Soltys, C. Ashokkumar, G. Mazariegos, G. Bond, M. Ningappa, A. Khanna, A. Ganoza, Q. Sun, R. Sindhi.
Increased Risk of Early Graft Loss in Pancreas Transplant: A Retrospective Review of the UNOS Database

E. Steen,¹ C. Liu,² E. Siskind,² J. Ortiz.¹
Increasing Obesity and Diabetes Prevalence in the United States End-Stage Renal Disease Population

B. Shelton,¹ D. McWilliams,¹ P. MacLennan,¹ R. Reed,¹ M. Mustian,¹ D. Sawinski,² J. Locke.
Increasing Obesity Prevalence in the United States Pediatric End-Stage Renal Disease Population

B. Shelton,¹ P. MacLennan,¹ R. Reed,¹ M. Mustian,¹ D. McWilliams,¹ D. Sawinski,² J. Locke.¹
Increasing the Donor Pool for Highly Sensitized Patients with Allele Specific Antibodies: Optimizing the Virtual Crossmatch (vXM)

A. Zhang,¹ Z. Zaky,² J. Africa,³ D. Good,¹ R. Bray,⁴ H. Gebel.⁴
Increasing Use of Exceptions after Changes to Pediatric Heart Allocation

A. Robinson,¹ W. Mahle,² R. Davies.³
Individualized Immunosuppression through Risk-Stratification in Renal Transplantation Preserves Excellent Outcomes at Three Years

J. Dann, A. Agarwal, M. Bradley, J. Geyston, W. Ally.
Induction Agents and Post-Transplant Malignancies in Kidney Transplants: An Examination of Outcomes at a Large Volume Center over 20 Years

D. Livingston-Rosanoff, X. Wang, G. Leverson, D. Kaufman, D. Foley.
Induction Therapy with Low-Dose Rituximab Could Be a Risk Factor of BKV Associated Nephropathy in Kidney Transplant Recipients

R. Murakami,¹ D. Nagawa,¹ M. Nakata,¹ I. Narita,¹ T. Fujita,¹ M. Shimada,¹ N. Nakamura,¹ H. Tomita,¹ S. Hatakeyama,² T. Yoneyama,² Y. Hashimoto,² T. Koie,² C. Ohyama.²
Induction Type and Outcomes in HLA-DR Mismatch Kidney Transplantation

K. Sureshkumar, S. Hussain, B. Chopra.
Infection Outcomes in Solid Organ Transplant Recipients Receiving Trimethoprim-Sulfamethoxazole as Opposed to Atovaquone for Prophylaxis

A. Drelick,¹ W. Mowrey,² G. Minamoto.³
Infectious Complications Associated with Eculizumab Used for ABO-Incompatible Renal Transplantation

M. Campara, P. West-Thielke, K. Progar, N. Jasiak, A. Lichvar, I. Tang, E. Benedetti.
Inferior Patient and Graft Survival in Highly Sensitized Adult Kidney Transplant Recipients with a Prior Transplant Compared to Pediatric Kidney Transplant Recipients: An Analysis of OPTN Data

P. Almond,¹ S. Al-Akash,¹ D. Stewart,² A. Robinson.²
Inflammation in Fibrotic Areas (i-IF/TA) Identifies a T Cell-Mediated Rejection Component of IF/TA with Poor Kidney Allograft Outcome

D. Viglietti, O. Aubert, J-.P. Duong Van Huyen, A. Loupy, C. Lefaucheur.
Inflammation in Scarred Areas (i-IF/TA): Defining the Response to Standard Treatment of T Cell-Mediated Rejection in Kidney Recipients

D. Viglietti, O. Aubert, J-.P. Duong Van Huyen, A. Loupy, C. Lefaucheur.
Inflammation in Scarred Areas (I-IFTA) is a Reflection of Parenchymal Injury (Response to Wounding) Not T Cell-Mediated Rejection

P. Halloran, J. Chang, K. Famulski.
Inflammatory Frailty Index and Mortality after Kidney Transplantation

C. Haugen, H. Ying, M. McAdams-DeMarco, D. Segev.
Influence of 6 Months Protocol Biopsies with and without Intervention on Course of GFR after Pediatric Renal Transplantation

L. Pape, C. Lerch, T. Ahlenstiel-Grunow, J. Bräsen, N. Kanzelmeyer.
Influence of Dendritic Cell Subsets on Enhancing Oral Tolerance in Cardiac Transplantation Model

G. Gu, T. Lu, N. Xu, Q. Xia.
Influence of Initial Tumor Burden and Wait Times on Post-Transplant Outcomes after Down-Staging of Hepatocellular Carcinoma (HCC)

N. Mehta, J. Dodge, F. Yao.
Influence of Liver Allograft Steatosis on Postoperative Acute Kidney Injury

C. Jadlowiec,¹ S. Mao,² D. Abdelwahab,¹ A. Nehra,² T. Taner.²
Influence of mTOR Inhibitors on Metabolic Outcomes One Year after Kidney Transplantation: The Role of Pre-Transplantation Diabetes

D. Cucchiari,¹ S. Karam,² P. Ventura-Aguiar,¹ J. Torregrosa,¹ F. Diekmann.¹
Influence of Trough Level in Tacrolimus on the Appearance Rate of De Novo Donor Specific Antibody (dnDSA) under Low Dose-Based Tacrolimus Protocol during 7 Years Follow-Up after Renal Transplantation

H. Ishida,¹ K. Tanabe,² T. Shimizu,¹ M. Furusawa.²
Influence of X-Ray Repair Cross-Complementing Group (XRCC) Genes Polymorphisms on the Development of Antibody-Mediated Rejection (ABMR) in Renal Transplant Recipients

Z. Wang, Z. Han, J. Tao, R. Tan, M. Gu.
Informatics Tools for Mapping Molecular HLA Typing Data to UNOS Antigen Equivalencies

N. Kaur,¹ E. Kransdorf,² M. Pando,³ M. Maiers,⁴ L. Gragert.^1,4
Information Needs of Adolescent Transplant Recipients Transitioning to Adult Care

B. Kosmach-Park,¹ D. Shellmer,² C. Nguyen,³ G. Mazariegos.²
Informed Clustering of Donor Service Areas for Better Benchmarking

S. Noreen, R. Carrico, J. Rosendale.
Inhibition of IL-1R1 Signaling Delays Costimulation Blockade–Resistant Allograft Rejection by Preventing CD8 TEM Expansion

Y. Liu, Y. Dong, D. Mathews, A. Ghosh, A. Adams.
Inhibition of Neutrophil Recruitment and Activation Protects Airway Epithelium after Transplantation

R. Zhang,¹ H. Fang,¹ Q. Chen,² J. Ochando,³ Y. Ding,¹ J. Xu.¹
Innovative Strategies to Accommodate Increased Patient Volume in an Outpatient Transplant Infusion Center

J. Estrada, M. Tyrell, J. Choi, J. Jagolino, S. Jordan.
Institution-Based, Pharmacist-Managed Anticoagulation in Patients with a Left Ventricular Assist Device

T. Bibb,¹ L. Halder,¹ D. McDanel,¹ A. Briasoulis,² P. Alvarez,² K. Horner,¹ J. Bhama,³ S. Larson.³
Insulin Use after Pancreas Transplant: Implications for Post-Transplant Outcomes

R. Ouseph, K. Lentine,¹ Z. Zhang,¹ D. Axelrod,² H. Randall,¹ B. Kasiske,³ A. Israni,³ V. Dharnidharka,⁴ T. Alhamad,⁴ D. Brennan,⁵ D. Segev,⁵ G. Hess,⁶ M. Schnitzler.¹
Insulin Use on Intensive Care Units as a Marker of beta-Cell Death in Brain Dead Pancreas Donors

M. Shapey,^1,2 A. Summers,² J. O'Sullivan,² P. Yianoullou,^1,2 T. Augustine,² M. Rutter,¹ D. van Dellen.²
Integration of Blood Type Incompatibility Desensitization Protocols into Kidney Paired Donation (KPD) Programs

F. Karami,¹ M. Nayebpour,² M. Gentili,¹ N. Koizumi,² K. Melancon.³
Intensified Immunosuppression Improves Early Renal Allograft Function after Transplantation in a Porcine Model with Extended Asystolic Warm Ischemic Time

M. Xu,¹ X. Wang,¹ S. Garcia-Aroz,¹ B. Banan,¹ B. Rabe,¹ Z. Zhang,¹ J. Jia,¹ G. Upadhya,¹ P. Manning,² J. Gaut,³ Y. Lin,¹ W. Chapman.¹
Intention to Treat Outcomes of Patients with Hepatocellular Carcinoma Downstaged to within Milan

P. Tabrizian,¹ M. Holzner,¹ J. Emond,² S. Florman,¹ R. Brown,² M. Schwartz,¹ K. Halazun.²
Intentional Transplantation of Hepatitis C Positive Livers into Hepatitis Negative Recipients- Report of the First Case-Series in the World

P. Martins, B. Movahedi, A. Ahearn, A. Bozorgzadeh.
Inter-Correlations between Psycho-Social Pre-Transplant Determinants of Post-Transplant Kidney Allograft Function

S. Shah, A. Gamilla-Crudo, B. Schreiber, C. Machner, O. Aleter, M. Mujtaba.
Interactive Software for Simulation and Management of a Kidney Paired Donation Program

M. Bray,¹ W. Wang,¹ M. Rees,² P. Song,¹ A. Leichtman,³ V. Ashby,¹ J. Kalbfleisch.¹
Interferon-b Promotes Regulatory T Cell (Treg) Induction and Prolongs Allograft Survival

M. Fribourg,¹ M. McGinty,² A. Angeletti,² M. Demir,² S. Sealfon,¹ P. Heeger,² P. Cravedi.²
Interim Results of the kSORT in the SAILOR Randomized Multicenter Trial

P. Lindner,¹ A. Shroeder,² J. Ekberg,¹ S. Hsieh,² P. Towfighi,² I. Damm,² T. Sigdel,² M. Sarwal.²
Interstitial Inflammation is Correlated with DQ Antibodies in Kidney Transplant Recipients

C. Harris, L. Anderson, R. Khaim, J. Choudhuri, R. Shapiro, S. Florman, F. Salem, M. Menon.
Intervention for Splenorenal Shunt May Decrease the Incidence of Post-Liver Transplant Acute Kidney Injury

J. Wang, A. Nickkholgh, R. Shahbazov, S. Pelletier, D. Maluf.
Intestinal Microbiome Diversity is Associated with Liver Disease Etiology and Predicts Post-Liver Transplant Mortality

E. Verna, M. Annavajhala, M. Nenad, R. Brown, S. Sullivan, G. Korakani, M. Gidins, S. Khan, A. Gomez-Simmonds, A-.C. Uhlemann.
Intra- versus Extra-Peritoneal Approaches in Renal Transplantation of Adult-Sized Kidneys for Children Weighting under 15kg – A Single Center Study

T. Mizutani,¹ M. Muramatsu,¹ Y. Hamasaki,² Y. Takahashi,² Y. Itabashi,¹ J. Hashimoto,² Y. Hyodo,¹ K. Sakurabayashi,¹ T. Kawamura,¹ S. Shihido.^1,2
Intragraft Gene Expression Differentiates Polyomavirus Nephropathy from T-Cell Mediated Rejection

B. Adam,¹ S. Wagner,¹ J. Bräsen,² V. Bröcker,² V. D'Agati,³ C. Drachenberg,⁴ E. Farkash,⁵ A. Farris,⁶ L. Geldenhuys,⁷ A. Magil,⁸ V. Nickeleit,⁹ P. Randhawa,¹⁰ H. Regele,¹¹ M. Mengel.¹
Intragraft MicroRNA Transcriptome of Acute Antibody Mediated Rejection of Human Kidney Allografts

H. Yang,¹ K. Akat,² C. Li,¹ C. Snopkowski,¹ Z. Khan,¹ D. Dadhania,¹ T. Tuschl,² M. Suthanthiran,¹ T. Muthukumar.¹
Intragraft MicroRNAs Foretell Fibrosis in Kidney Transplant Recipients

H. Yang,¹ L. Amrouche,² K. Akat,³ C. Li,¹ Z. Khan,¹ C. Tinel,² T. Tuschl,³ D. Anglicheau,² T. Muthukumar.¹
Intraoperative Blood Loss during Pediatric Liver Transplantation: A Single Center Experience

J. Kohler,¹ D. Yoeli,¹ R. Sigireddi,¹ R. Ackah,¹ M. Kueht,² T. Galvan,² R. Cotton,² A. Rana,² C. O'Mahony,² J. Goss.²
Intravenous Immunoglobulins and Methylprednisolone Stabilizes Renal Allograft Function in the Majority of Patients with C-aABMR

K. Sablik, M. Clahsen-van Groningen, C. Looman, J. Damman, M. van Agteren, M. Betjes.
Introduction of Direct Acting Antivirals for HCV: Fewer Kidney Discards but a Long Way to Go

T. Alhamad,¹ R. Thakkar,¹ D. Brennan,² J. Lappin,³ B. Kaplan,³ A. Malone,¹ V. Hicks,¹ J. Wellen,¹ K. Lentine.⁴
Investigating the Variability of Fluid Resuscitation during Laparoscopic Donor Nephrectomy

A. Williams,¹ S. Kumar,² R. Sung,¹ K. Woodside,¹ M. Englesbe,¹ M. Alameddine,¹ S. Waits.¹
Investigation of Lower Treatment Failure Rate Seen among Black Kidney Recipients on LCP-Tacrolimus vs. IR-Tacrolimus: Subgroup Analyses of Two Phase 3 Trials

T. Sparkes,¹ B. Masters,¹ C. Staino,² S. Patel,² M. Cooper.³
Involvement of Additional Surgeons in Robot Assisted Kidney Transplantation Does Not Affect Surgical Outcomes, in the Context of a Structured Robotic Surgery Program. Results from a CUSUM Analysis

F. Gheza,¹ C. Di Bella,¹ P. Giulianotti,¹ J. Oberholzer,² E. Benedetti,¹ I. Tzvetanov.¹
Involvement of Aldehyde Dehydrogenase 2 (ALDH2) in Fatty Liver Graft Protection Mechanisms against Cold Ischemic Injury

A. Panisello-Rosello,¹ A. Lopez,² C. Castro,² S. Bellogi,¹ E. Folch-Puy,¹ A. Rolo,³ C. Palmeira,³ R. Adam, J. Roselló-Catafau.
Involvement of PD-L1 Upregulation in Anti-A/B Antibody-Induced Graft Accommodation: Reduction of CD4 T Cell Allo-Response against Graft HLA Class II DR

K. Iwasaki,¹ Y. Miwa,¹ H. Hamana,³ H. Kishi,³ A. Muraguchi,³ K. Uchida,¹ T. Kobayashi.²
Is Age a Potential Barrier to Pursuing Living Donor Kidney Transplant (LDKT)?

A. Raissi, N. Edwards, Y. Liao, D. Belenko, N. Singh, M. Khalid, D. Toews, I. Mucsi.
Is BMI > 35 a Barrier to Kidney Transplantation?

D. Walczak, E. Benedetti, C. Ryan.
Is It Better Choice to Perform Kidney Transplantation for Elderly CKD Patients?

R. Imamura,¹ K. Tsutahara,² K. Yamanaka,³ M. Kawamura,¹ S. Nakazawa,¹ T. Kato,¹ T. Abe,¹ H. Kishikawa,³ N. Ichimaru,⁴ K. Nishimura,³ S. Yamaguchi,² N. Nonomura.¹
Is KDPI Valid for Hepatitis C Aviremic Kidneys?

L. Sibulesky,¹ C. Kling,¹ C. Blosser,² C. Johnson,² A. Limaye,² R. Bakthavatsalam,¹ N. Leca,² J. Perkins.¹
Is Kidney Transplantation Safe in Patients over 71 Years Old?

G. Andani, P. Tulissi, M. Gropuzzo, S. Crestani, C. Vallone, U. Baccarani, D. Montanaro, A. Risaliti.
Is Percent Exception at Transplant a Driver of MELD Inflation?

D. Schladt,¹ J. Snyder,¹ A. Israni,¹ W. Kim,² J. Lake.³
Is Renal Function after Heart Transplantation an Issue for Patients with Cardiac Amyloidosis?

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Is the NETos Increased in Acute Antibody Mediated Rejection?

R. Villca-Gonzales,¹ J. Torres-Ruiz,² D. Gomez-Martin,² J. Alberu,³ L. Morales-Buenrostro.¹
Isavuconazole – The Real-World Use Experience

H. Hassouna, V. Athans, K. Brizendine.
Ischemia Reperfusion Injury & Risk for Antibody Mediated Rejection (ABMR) in HLA Sensitized Patients Treated with C1 Esterase Inhibitor (C1INH)

A. Vo,¹ O. Aubert,² J. Choi,¹ N. Ammerman,¹ H. Edmund,¹ A. Peng,¹ R. Najjar,¹ S. Supreet,¹ S. Jordan.¹
Ischemia Reperfusion Injury in Liver Transplantation is Associated with Acute Kidney Injury: Role of Inflammatory Mediators

P. Mihaylov,^1,2 P. Li,¹ J. Skill,¹ L. Timsina,¹ J. Fridell,¹ B. Ekser,¹ R. Mangus,¹ C. Kubal.¹
Ischemia Reperfusion Injury Significantly Differs between Lung vs. Heart Transplantation with Respect to Lead Cytokines and Correlation to Clinical Outcome

B. Wiegmann,¹ N. Ledwoch,² J. ISke,² C. Neudörfl,² I. Tudorache,¹ C. Kühn,¹ T. Kaufeld,¹ F. Ius,¹ S. Rojas,¹ M. Avsar,¹ A. Haverich,¹ G. Warnwcke,¹ C. Falk.¹
Ischemia-Free Liver Transplantation for Fatty Liver Grafts in Human

W. Ju, S. Huang, Z. Guo, G. Chen, X. He.
Ischemia-Free Liver Transplantation in Pigs: Ischemia Reperfusion Injury is Avoidable?

Z. Guo, X. He, Y. Tang, F. Ji, Z. Zhang, Q. Zhao, S. Huang, Z. Zhu, W. Ju, G. Chen.
Ischemic Preconditioning Ameliorates Renal Ischemia-Reperfusion Injury in Mice via Heme Oxygenase-1-Mediated Autophagy

J. Hwang,² H. Choi,¹ M. Kim,² K. Jun,² K. Kown,² S. Park,² J. Kim,² I. Moon.²
Islet Xenotransplantation: A Quest for Clinically Available Immunosuppression Regimens

Q. Gao, R. Davis, M. Mulvihill, M. Song, F. Leopardi, M. Ribeiro, T. How, G. Devi, B. Collins, A. Kirk.
Isolated Pancreas Transplantation: Does Rank List Position Matter for Imported Grafts?

J. Adler, R. Redfield, D. Kaufman, J. Odorico.
Isolated Pre-Transplant Angiotensin II Type I Receptor Antibodies (AT1R Ab) Are Not Associated with Reduced Graft Function or Hypertension (HTN) in Pediatric Kidney Transplant (Ped KTx) Patients (pts)

H. Pizzo, J. Choi, M. Haas, X. Zhang, E. Kamil, I. Kim, S. Jordan, D. Puliyanda.
Isolated Right Hepatic Vein (RHV) Obstruction after Piggyback Liver Transplantation, an Infrahepatic Terminolateral Cavo-Cavostomy as a Rescue Technique to Save the Graft

K. Pineda-Solis, C. Florez-Zorrilla, A. Sanchez-Cedillo, L. Ladrón de Guevara-Cetrina.
Isolation and Profiling of miRNAs from Formalin Fixed Paraffin Embedded Endomyocardial Tissues from Human Heart Transplant Recipients

R. Nog,^1,2 C. Gupta,^1,2 J. Fallon,^1,2 J. Panza,^1,2 N. Haque.²
Itraconazole Prophylaxis, Trough Concentration, and Identification of Fungal Pathogens in Lung Transplant

H. Hassouna, V. Athans, K. Brizendine.
IVIG Induction May Be Helpful in Highly Sensitized Patients after Heart Transplantation

J. Patel, M. Kittleson, E. Kransdorf, R. Levine, S. Dimbil, D. Geft, D. Chang, L. Czer, J. Kobashigawa.